Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × OTHER × Antibodies, Bispecific × Clear all

Status

Recruiting 3 Withdrawn 1 Terminated 1 Not yet recruiting 1 Completed 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

3-Iodobenzylguanidine 3 mifamurtide 1 fluorodopa F 18 1 fluorocholine 1 epigallocatechin gallate 1 carbon-11 methionine 1 Vaccination 1 Peripheral Blood Stem Cell Transplantation 1 Methionine 1 Magnetic Resonance Spectroscopy 1 Immunotherapy, Adoptive 1 Imatinib Mesylate 1 Eflornithine 1 Domperidone 1 Dasatinib 1 Bortezomib 1 Bone Marrow Transplantation 1 Antibodies, Bispecific 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05119257 2024-05-08

InHeAb01

University Hospital Tuebingen

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡